Lloyd Tran
Lloyd Tran is an expert in Neurology at Biomed Resource Inc. (United States). Lloyd Tran has authored 13 publications, the most recent in 2021, and is an investigator in 6 clinical trials, 2 of them ongoing. SLR score: 364 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Psychiatry - Pharmacy - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2021 - 2025
Number : 13
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
Most recent indexed article
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Aduhelm: The Best Hope for Alzheimer's Disease Patients or the Worst Decision the FDA Has Ever Made? PMID 34657888 — alzheimer disease | J Alzheimers Dis | 2021 | 6 |
Clinical Studies 6
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| To Investigate the Efficacy of Treatment With Oral NA 921 (Bionetide) Versus Placebo in Females With Rett Syndrome NCT06840496 — solutions, therapeutics, gastrostomy, mouth, rett syndrome, genetic diseases, x-linked, genetic diseases, inborn, genes, x-linked, female, women | Phase 3 | Recruiting | 2026 |
| Safety and Efficacy of NA 931 and Tirzepatide in Adults Who Are Overweight or Obese NCT06732245 — glucagon-like peptide 1, glucagon-like peptide-1 receptor, safety, multiple chronic conditions, obesity, glucagon, overweight, names, glucagon-like peptides, men, women | Phase 2 | Not yet recruiting | 2026 |
LeadR Networks
Main global connection map